Image

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Description

The goal of the BrainGate2 research and development project is to identify the core methods and features for a medical device that could allow people with paralysis, including severe speech impairment, to recover a host of abilities that normally rely on the hands or on speech.

Eligibility

Inclusion Criteria:

  • Participants must have a diagnosis of amyotrophic lateral sclerosis (ALS) as verified by a clinical expert in neurologic diseases.
  • Participants with a diagnosis of ALS with anarthria, or severe dysarthria with decline in the preceding four months.

Exclusion Criteria:

  1. Between 18 and 80 years of age.
  2. The patient must be able to speak understandably or if unable to speak understandably must have one reliable means of communication.
  3. Complete or incomplete tetraplegia (quadriplegia)
  4. A minimum of twelve months elapsed post-injury and recovery must have plateaued at least 3 months prior to baseline screening.
  5. Per clinical opinion, a life expectancy of greater than 6 months.
  6. Must be within a three-hour drive of the Study site and geographically stable for at least 15 months after enrollment.

(There are additional exclusion criteria)

Study details
    Anarthria
    Dysarthria
    Tetraplegia
    Spinal Cord Injuries
    Amyotrophic Lateral Sclerosis
    Brain Stem Infarctions
    Locked in Syndrome
    Muscular Dystrophies

NCT05724173

Leigh R. Hochberg, MD, PhD.

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.